End In Sight For Ovarian Cancer Patients With $5.5B+ J&J Deal
By Emily Field · July 31, 2026, 6:54 PM EDT
The $5.5 billion global deal over talc ovarian cancer allows women to move past recent court setbacks requiring them to provide experts who can show a causal link between their disease...
To view the full article, register now.